The publication explores cancer not merely as a genetic disease, but significantly as a metabolic dysfunction. It posits that alterations in cellular energy production play a critical role in tumor initiation, progression, and response to therapy. The work integrates biochemistry, cell biology, and clinical oncology to present a comprehensive framework for understanding the disease.
This perspective offers potential advantages, including the development of targeted therapies that exploit metabolic vulnerabilities in cancer cells. This could lead to treatments with fewer side effects compared to conventional approaches. Its roots lie in decades of research highlighting the Warburg effect, where cancer cells preferentially utilize glycolysis even in the presence of oxygen.
